Latest Lead News

Page 74 of 464
InhaleRx Limited has successfully closed its entitlement offer and placement, raising $857,730 to support the clinical development of inhaled treatments targeting cancer pain and mental health conditions.
Ada Torres
Ada Torres
23 Dec 2025
Perseus Mining has expanded and refinanced its corporate debt facility to US$400 million, significantly enhancing its liquidity position to over US$1.2 billion. This move positions the gold miner strongly for future growth and shareholder returns.
Maxwell Dee
Maxwell Dee
23 Dec 2025
The Supreme Court of New South Wales has approved Southern Cross Media's acquisition of Seven West Media, setting the stage for a significant media industry consolidation early next year.
Elise Vega
Elise Vega
23 Dec 2025
Wingara AG Limited has arranged a $250,000 unsecured loan facility from NAOS Asset Management entities, featuring a convertible note option that could reshape its capital structure.
Ada Torres
Ada Torres
23 Dec 2025
American Tungsten & Antimony Ltd plans to unlock value by spinning out its Drummond Basin and NSW gold exploration assets into a new ASX-listed company, King Metals Limited, aiming to raise up to $6 million in an IPO.
Maxwell Dee
Maxwell Dee
23 Dec 2025
Chimeric Therapeutics has raised $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 trial through Phase 1, while initiating a strategic reset to sharpen focus and reduce costs.
Ada Torres
Ada Torres
23 Dec 2025
Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.
Ada Torres
Ada Torres
23 Dec 2025
Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.
Ada Torres
Ada Torres
23 Dec 2025
Elevate Uranium Ltd has expanded its global uranium resource to 169 million pounds of U3O8 through the acquisition of the Napperby Uranium Project and complementary assets from Core Lithium Ltd. This move consolidates its Central Australian portfolio and leverages its proprietary U-pgrade™ beneficiation technology.
Maxwell Dee
Maxwell Dee
23 Dec 2025
Elevate Uranium has expanded its global uranium resource base to 169 million pounds of U3O8 through the strategic acquisition of the Napperby Uranium Project and complementary assets from Core Lithium. This move consolidates its Central Australian portfolio and leverages its proprietary U-pgrade™ beneficiation technology.
Maxwell Dee
Maxwell Dee
23 Dec 2025
Artrya Limited has signed a significant five-year commercial agreement with Cone Health, marking its third U.S. customer and solidifying its foothold in the American healthcare market with its AI-powered Salix platform.
Ada Torres
Ada Torres
23 Dec 2025
AusQuest Limited’s recent reconnaissance drilling at its Mt Davis Project in Western Australia has revealed promising lead, copper, and silver anomalies, suggesting potential for sediment-hosted base metal deposits.
Maxwell Dee
Maxwell Dee
23 Dec 2025